0001683168-23-002405.txt : 20230414
0001683168-23-002405.hdr.sgml : 20230414
20230414162005
ACCESSION NUMBER: 0001683168-23-002405
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230412
FILED AS OF DATE: 20230414
DATE AS OF CHANGE: 20230414
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Climaco John M
CENTRAL INDEX KEY: 0001546797
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39126
FILM NUMBER: 23821429
MAIL ADDRESS:
STREET 1: PO BOX 326
CITY: PARK CITY
STATE: UT
ZIP: 84060
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CNS Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001729427
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 822318545
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 WEST LOOP SOUTH
STREET 2: SUITE 900
CITY: HOUSTON
STATE: TX
ZIP: 77027
BUSINESS PHONE: 1-800-946-9185
MAIL ADDRESS:
STREET 1: 2100 WEST LOOP SOUTH
STREET 2: SUITE 900
CITY: HOUSTON
STATE: TX
ZIP: 77027
4
1
ownership.xml
X0407
4
2023-04-12
0
0001729427
CNS Pharmaceuticals, Inc.
CNSP
0001546797
Climaco John M
C/O CNS PHARMACEUTICALS, INC.
100 WEST LOOP SOUTH, SUITE 900
HOUSTON
TX
77027
1
1
0
0
Chief Executive Officer
0
Common Stock
2023-04-12
4
P
0
15000
0.6939
A
45010
D
This transaction was executed in multiple trades at prices ranging from $0.677 to $0.70. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ John M. Climaco
2023-04-14